NON-IONIC SURFACTANT VESICLES (NIOSOMES) BASED NOVEL OPHTHALMIC FORMULATION OF TIMOLOL MALEATE

  • Prakash Kumar Soni Nanotechnology Research Lab., Department of Pharmacy, Shri G.S. Institute of Technology and Science, 23- Park Road, Indore-452003, (MP) India
  • T R Saini Nanotechnology Research Lab., Department of Pharmacy, Shri G.S. Institute of Technology and Science, 23- Park Road, Indore-452003, (MP) India

Abstract

The objective of the present work was to develop drug loaded niosomal ophthalmic formulation of timolol maleate (an antiglaucomal drug) for enhanced trans-corneal drug permeation and better ocular bioavailability. Timolol loaded niosomes were prepared by thin film hydration method using rotary evapoarator and ultra-sonicated for size reducation using probe sonicator. The nano-vesicle (niosomal) formulation was optimized by selecting surfactant content, cholesterol content and sonication time as independent variables and particle (vesicle) size, drug entrapment efficiency and % drug release as response variables for optimization studies. The timolol maleate niosomal (TMN) formulation was evaluated for particle size, pH and osmolality  and was found to possess the desired properties. The developed TMN formulation was studied for % cumulative in-vitro drug release using bottle rotating apparatus (electrolab) and was found to be 79.98% over 8 hr period exhibiting sustained drug release profile. The ex-vivo trans-corneal drug permeation profile of developed TMN was studied using modified franz-diffusion cell apparatus (Permegear) and the % cumulative drug permeation across freshly excised goat cornea was found to be 65.90 % in 8 hrs duration, which was approximately 1.5 times higher than the conventional eye drop formulation. The developed TMN was also proved to be isotonic and non-irritant in HET-CAM ocular irritancy test. It was therefore, concluded from above studies, that the developed timolol maleate niosomal (TMN) formulation is better than conventional eye drops due to longer corneal retention, sustained drug release and better trans-corneal drug permeation and thereby higher ocular bioavailability, hence, would need less frequent administration. 

Downloads

Download data is not yet available.

Author Biographies

Prakash Kumar Soni, Nanotechnology Research Lab., Department of Pharmacy, Shri G.S. Institute of Technology and Science, 23- Park Road, Indore-452003, (MP) India

Nanotechnology Research Lab., Department of Pharmacy, Shri G.S. Institute of Technology and Science, 23- Park Road, Indore-452003, (MP) India

T R Saini, Nanotechnology Research Lab., Department of Pharmacy, Shri G.S. Institute of Technology and Science, 23- Park Road, Indore-452003, (MP) India

Nanotechnology Research Lab., Department of Pharmacy, Shri G.S. Institute of Technology and Science, 23- Park Road, Indore-452003, (MP) India

References

1. Uchegbu IF, Vyas SP, Non-ionic surfactant based vesicles (niosomes) in drug delivery, Int J Pharm, 1998, 33-70.
2. Mancon M, Sinico C, Valenti D, Loy G, Fadda AM, Accelerated photostability study of tretinoin and isotretinoin in liposome formulations, Int J Pharm, 2002, 237-248.
3. Aggarwal D, Kaur I, Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system, Int J Pharm, 155-159.
4. Zhanrong Q, Zeng W, The Development of a Butyrylcholinesterase Porous Pellet for Innovative Detection of Cholinesterase Inhibitors, Eur J of Pharm Sci, 115-123.
Statistics
78 Views | 82 Downloads
How to Cite
Soni, P., & Saini, T. (2017). NON-IONIC SURFACTANT VESICLES (NIOSOMES) BASED NOVEL OPHTHALMIC FORMULATION OF TIMOLOL MALEATE. Journal of Drug Delivery and Therapeutics, 7(7), 59-61. https://doi.org/10.22270/jddt.v7i7.1587